Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
United States
Antihemophilic factor

FDA 2014

Antihemophilic factor

Eloctate

250IU For InjectionUnited StatesMarketedAuthorised 6 Jun 2014

Ask Osler about it

On this page

In other countries
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

EloctateCanada · 2000 UNIT / VIAL · Kit, Powder For Solution · Sanofi-Aventis Canada INCSame brand
EloctateCanada · 1000 UNIT / VIAL · Kit, Powder For Solution · Sanofi-Aventis Canada INCSame brand
EloctateCanada · 1500 UNIT / VIAL · Kit, Powder For Solution · Sanofi-Aventis Canada INCSame brand
Advate 1000 Ui Polvo y Disolvente Para Solucion InyectableSpain · 1000 UI · polvo y disolvente para solución inyectable · Takeda Manufacturing Austria AgSame form
Advate 1500 Ui Polvo y Disolvente Para Solucion InyectableSpain · 1500 UI · polvo y disolvente para solución inyectable · Takeda Manufacturing Austria AgSame form
Advate 2000 Ui Polvo y Disolvente Para Solucion InyectableSpain · 2000 UI · polvo y disolvente para solución inyectable · Takeda Manufacturing Austria Ag

More with the same substance on this register

AdynovateAntihemophilic factor · 2000IU · For InjectionUnited States
AdynovateAntihemophilic factor · 1500IU · For InjectionUnited States

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Same form

🇭🇷Emoclot 100 IU/ml prašak i otapalo za otopinu za injekciju/infuzijuCroatia · Prašak i otapalo za otopinu za injekciju / infuziju · Kedrion S.p.A., Ai Conti, Castelvecchio Pascoli, Barga (Lucca), ItalijaSame form

🇭🇷Emoclot 50 IU/ml prašak i otapalo za otopinu za injekciju/infuzijuCroatia · Prašak i otapalo za otopinu za injekciju / infuziju · Kedrion S.p.A., Ai Conti, Castelvecchio Pascoli, Barga (Lucca), ItalijaSame form

🇭🇷Octanate 1000 IU prašak i otapalo za otopinu za injekcijuCroatia · prašak i otapalo za otopinu za injekciju · Jana Pharm d.o.o., Lopašićeva 6, Zagreb, HrvatskaSame form

🇮🇹AdvateItaly · Polvere e solvente per soluzione iniettabile · Takeda Manufacturing Austria AGSame form

🇮🇹AdynoviItaly · Polvere e solvente per soluzione iniettabile · Baxalta Innovations GMBHSame form

🇮🇹AfstylaItaly · Polvere e solvente per soluzione iniettabile · CSL Behring GMBHSame form

🇳🇱Advate 1000 IU, poeder en oplosmiddel voor oplossing voor injectie 200 IU/mlNetherlands · Poeder en oplosmiddel voor oplossing voor injectie · Takeda Manufacturing Austria AGSame form

🇳🇱Advate 1000 IU, poeder en oplosmiddel voor oplossing voor injectie 500 IU/mlNetherlands · Poeder en oplosmiddel voor oplossing voor injectie · Takeda Manufacturing Austria AGSame form

🇳🇱Advate 1500 IU, poeder en oplosmiddel voor oplossing voor injectie 300 IU/mlNetherlands · Poeder en oplosmiddel voor oplossing voor injectie · Takeda Manufacturing Austria AGSame form

🇳🇿AdvateNew Zealand · Inj 2,000 iu vialSame form

🇳🇿AdvateNew Zealand · Inj 3,000 iu vialSame form

🇳🇿AdvateNew Zealand · Inj 1,000 iu vialSame form

🇷🇴Advate 1000UIRomania · 1000UI · pulb+solv.pt.sol.inj · Baxter AGSame form

🇷🇴Advate 1000UIRomania · 1000UI · pulb. + solv. pt. sol. inj. · Takeda Manufacturing Austria AGSame form

🇷🇴Advate 1500UIRomania · 1500UI · pulb+solv.pt.sol.inj · Baxter AGSame form

🇷🇸AdvateSerbia · 500i.j./5mL · prašak i rastvarač za rastvor za injekciju · Takeda DOOSame form

🇷🇸AdvateSerbia · 1000i.j./5mL · prašak i rastvarač za rastvor za injekciju · Takeda DOOSame form

🇷🇸AdvateSerbia · 250i.j./5mL · prašak i rastvarač za rastvor za injekciju · Takeda DOOSame form

🇸🇦Alphanate 250 IU Vial+5ML DiluentSaudi Arabia · Grifols BiologicalsSame form

🇸🇦Dried Factor Viii Type 8Y 25IU-ML VialSaudi Arabia · Bio-Product LabSame form

🇸🇦Dried Factor Viii Type 8Y 25IU-ML VialSaudi Arabia · Bio-Product LabSame form

🇸🇬ADVATE 1000 IU Powder and Solvent for Solution for InjectionSingapore · 1000 IU · injection, powder, lyophilized, for solution · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.Same form

🇸🇬ADVATE 1500 IU Powder and Solvent for Solution for InjectionSingapore · 1500 IU · injection, powder, lyophilized, for solution · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.Same form

🇸🇬ADVATE 250 IU Powder and Solvent for Solution for InjectionSingapore · 250 IU · injection, powder, lyophilized, for solution · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.Same form

🇧🇷EmoclotBrazil · Kedrion Brasil Ltda.Same substance

🇧🇷FactaneBrazil · LFB - Hemoderivados e Biotecnologia LtdaSame substance

🇧🇷FanhdiBrazil · Grifols Brasil LtdaSame substance

🇪🇺AdvateEuropean Union · Takeda Manufacturing Austria AGSame substance

🇪🇺AdynoviEuropean Union · Baxalta Innovations GmbHSame substance

🇪🇺AfstylaEuropean Union · CSL Behring GmbHSame substance

🇹🇼Jivi 1000 IUTaiwan · 凍晶乾燥注射劑 · 台灣拜耳股份有限公司Same substance

🇹🇼Jivi 2000 IUTaiwan · 凍晶乾燥注射劑 · 台灣拜耳股份有限公司Same substance

🇹🇼Jivi 250 IUTaiwan · 凍晶乾燥注射劑 · 台灣拜耳股份有限公司Same substance

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

U.S. Food and Drug Administration

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions · Added 11 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Antihemophilic factor
Strength: 250IU
Dosage form: For Injection
Route: Intravenous
Register: United States (FDA)
Status: Marketed
Status in the register: Licensed / Rx
Authorised: 6 Jun 2014
Registration: BLA 125487
Marketing authorisation holder: Bioverativ Therapeutics, Inc.
Procedure: 351(a)
Supply: Rx

FDA

AdynovateAntihemophilic factor · 500IU · For Injection🇺🇸United States

FDAAdynovateAntihemophilic factor · 750IU · For Injection🇺🇸United States

FDAAdynovateAntihemophilic factor · 1000IU · For Injection🇺🇸United States

FDAAdynovateAntihemophilic factor · 250IU · For Injection🇺🇸United States

FDAAdynovateAntihemophilic factor · 3000IU · For Injection🇺🇸United States

FDABioclate (Armour), RecombinateAntihemophilic factor · 2000IU · For Injection🇺🇸United States

FDABioclate (Armour), RecombinateAntihemophilic factor · 1500IU · For Injection🇺🇸United States

FDABioclate (Armour), RecombinateAntihemophilic factor · 1000IU · For Injection🇺🇸United States

FDABioclate (Armour), RecombinateAntihemophilic factor · 250IU · For Injection🇺🇸United States

FDABioclate (Armour), RecombinateAntihemophilic factor · 500IU · For Injection🇺🇸United States